BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
JD-SW
09618
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 16.54%390.4M | 26.71%901.65M | -38.39%335M | -37.34%711.61M | 3.09%543.75M | 62.06%1.14B | 44.87%527.44M | -70.30%700.73M | -66.34%364.09M | 26.50%2.36B |
Operating income | 16.54%390.4M | 26.71%901.65M | -38.39%335M | -37.34%711.61M | 3.09%543.75M | 62.06%1.14B | 44.87%527.44M | -70.30%700.73M | -66.34%364.09M | 26.50%2.36B |
Cost of sales | -1.78%-342.39M | 29.19%-741.35M | 53.86%-336.41M | 30.52%-1.05B | -4.45%-729.04M | -28.93%-1.51B | -17.94%-698M | 34.56%-1.17B | 29.16%-591.81M | -32.62%-1.79B |
Operating expenses | -1.78%-342.39M | 29.19%-741.35M | 53.86%-336.41M | 30.52%-1.05B | -4.45%-729.04M | -28.93%-1.51B | -17.94%-698M | 34.56%-1.17B | 29.16%-591.81M | -32.62%-1.79B |
Gross profit | 3,519.66%48.01M | 147.80%160.29M | 99.24%-1.4M | 9.67%-335.36M | -8.64%-185.29M | 20.67%-371.25M | 25.10%-170.56M | -181.55%-467.98M | -192.44%-227.72M | 10.62%573.83M |
Selling expenses | -40.40%-61.31M | -32.40%-106.1M | 30.10%-43.67M | ---80.14M | -5.69%-62.47M | ---- | -29.76%-59.11M | ---- | ---45.55M | ---- |
Administrative expenses | 18.19%-70.76M | -7.41%-259.03M | 37.06%-86.5M | ---241.15M | 9.64%-137.44M | ---- | 17.88%-152.1M | ---- | ---185.22M | ---- |
Impairment and provision | -119.02%-35K | 96.86%-50K | 118.70%184K | ---1.59M | 99.60%-984K | ---- | -19,936.04%-248.74M | ---- | --1.25M | ---- |
-Other impairment is provision | -119.02%-35K | 96.86%-50K | 118.70%184K | ---1.59M | 99.60%-984K | ---- | -19,936.04%-248.74M | ---- | --1.25M | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | -66.02%-49.13M | ---- | 32.74%-29.59M | ---- | ---44M | ---- |
Special items of operating profit | -204.83%-6.47M | -105.61%-1.11M | 193.49%6.17M | -5.50%19.85M | -133.66%-6.6M | -52.32%21.01M | 19.94%19.62M | -53.76%44.06M | -47.92%16.36M | -28.36%95.28M |
Operating profit | 27.67%-90.57M | 67.73%-206M | 71.67%-125.21M | -82.27%-638.39M | 31.00%-441.92M | 17.38%-350.25M | -32.09%-640.48M | -163.36%-423.92M | -274.57%-484.88M | -83.61%669.12M |
Financing cost | -7.25%-97.25M | -84.45%-202.85M | ---90.67M | -68.15%-109.97M | ---- | 49.14%-65.4M | ---- | -36.97%-128.58M | ---- | 14.15%-93.88M |
Share of profits of associates | ---- | ---- | ---- | 75.11%-7.08M | 39.43%-7.08M | -11.00%-28.46M | -34.70%-11.7M | -529.67%-25.64M | -889.97%-8.68M | ---4.07M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | 47.61%-673.46M | ---- | -80.90%-1.29B | ---- | 53.29%-710.55M |
Earning before tax | 13.00%-187.82M | 45.88%-408.85M | 51.92%-215.89M | 32.40%-755.44M | 31.15%-449M | 40.03%-1.12B | -32.14%-652.18M | -1,237.00%-1.86B | -439.77%-493.56M | -105.69%-139.38M |
Tax | 6.01%2.86M | 172.49%403.93M | 107.39%2.7M | 303.42%148.24M | -0.11%-36.5M | 20.49%-72.87M | 35.61%-36.46M | -80.14%-91.65M | -252.63%-56.63M | 89.51%-50.87M |
After-tax profit from continuing operations | 13.24%-184.96M | 99.19%-4.92M | 56.09%-213.19M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B | -411.82%-550.19M | -109.68%-190.25M |
After-tax profit from non-continuing business | 144.49%75.04M | ---- | --30.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | 39.77%-109.93M | 99.19%-4.92M | 62.41%-182.5M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B | -411.82%-550.19M | -109.68%-190.25M |
Profit attributable to shareholders | 39.77%-109.93M | 99.19%-4.92M | 62.41%-182.5M | 48.99%-607.21M | 29.50%-485.51M | 39.11%-1.19B | -25.17%-688.64M | -927.66%-1.96B | -411.82%-550.19M | -109.68%-190.25M |
Basic earnings per share | 39.80%-0.0177 | 99.18%-0.0008 | 62.45%-0.0294 | 49.01%-0.0979 | 29.46%-0.0783 | 39.05%-0.192 | -24.72%-0.111 | -950.00%-0.315 | -423.53%-0.089 | -109.55%-0.03 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.